NDC 70518-2042
Tamiflu
Oseltamivir Phosphate
Tamiflu is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Oseltamivir Phosphate.
| Product ID | 70518-2042_87b62340-d5ec-1934-e053-2995a90aa49e |
| NDC | 70518-2042 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tamiflu |
| Generic Name | Oseltamivir Phosphate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021087 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | OSELTAMIVIR PHOSPHATE |
| Active Ingredient Strength | 75 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 70518-2042-0
1 BLISTER PACK in 1 CARTON (70518-2042-0) > 10 CAPSULE in 1 BLISTER PACK
| Marketing Start Date | 2019-04-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 70518-2042-0 [70518204200]
Tamiflu CAPSULE
| Marketing Category | NDA |
| Application Number | NDA021087 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-04-26 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| OSELTAMIVIR PHOSPHATE | 75 mg/1 |
NDC Crossover Matching brand name "Tamiflu" or generic name "Oseltamivir Phosphate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-0800 | Tamiflu | oseltamivir phosphate |
| 0004-0801 | Tamiflu | oseltamivir phosphate |
| 0004-0802 | Tamiflu | oseltamivir phosphate |
| 0004-0822 | Tamiflu | Oseltamivir Phosphate |
| 42254-001 | Tamiflu | oseltamivir phosphate |
| 42254-092 | Tamiflu | Oseltamivir Phosphate |
| 50090-0662 | Tamiflu | Tamiflu |
| 50090-1244 | Tamiflu | Tamiflu |
| 55045-2759 | Tamiflu | Tamiflu |
| 55045-3198 | Tamiflu | Tamiflu |
| 70518-2042 | Tamiflu | Tamiflu |
| 0093-8180 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 16714-817 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 16714-818 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 16714-819 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 27241-139 | Oseltamivir phosphate | Oseltamivir phosphate |
| 31722-108 | Oseltamivir phosphate | oseltamivir phosphate |
| 31722-630 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 31722-631 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 31722-632 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 42291-567 | Oseltamivir Phosphate | Oseltamivir Phosphate |
| 47781-468 | Oseltamivir Phosphate | Oseltamivir phosphate |
| 47781-384 | Oseltamivir Phosphate for Oral Suspension | Oseltamivir Phosphate |
Trademark Results [Tamiflu]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TAMIFLU 76055175 2576662 Live/Registered |
HOFFMANN-LA ROCHE INC. 2000-05-24 |
 TAMIFLU 75817157 not registered Dead/Abandoned |
HOFFMANN-LA ROCHE INC. 1999-10-06 |
 TAMIFLU 75691912 2439305 Live/Registered |
HOFFMANN-LA ROCHE INC. 1999-04-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.